Table 1 Study cohort.

From: Characterization of non-invasive oropharyngeal samples and nucleic acid isolation for molecular diagnostics

n = 59

41 males (m)

18 females (f)

Group 1 (n = 13)

11 m

2 f

Patients with symptoms that are not due to carcinoma

Group 2 (n = 8)

6 m

2 f

Patients with high tobacco/alcohol consumption and/or symptoms of carcinoma

Group 3 (n = 38)

24 m

14 f

a: Acute tumor—oropharyngeal carcinoma (n = 7)

b: Post diagnosis treatment (n = 31)

  1. Overview of the study cohort and patient grouping. Shown are the numbers of included patients, sex and grouping depending on the symptoms and status.